In humans, low peak bone mass is a significant risk factor for osteoporosis
. We report that LRP5, encoding the low-density lipoprotein receptor-relate
d protein 5, affects bone mass accrual during growth. Mutations in LRP5 cau
se the autosomal recessive disorder osteoporosis-pseudoglioma syndrome (OPP
G). We find that OPPG carriers have reduced bone mass when compared to age-
and gender-matched controls. We demonstrate LRP5 expression by osteoblasts
in situ and show that LRP5 can transduce Writ signaling in vitro via the c
anonical pathway. We further show that a mutant-secreted form of LRP5 can r
educe bone thickness in mouse calvarial explant cultures. These data indica
te that Wnt-mediated signaling via LRP5 affects bone accrual during growth
and is important for the establishment of peak bone mass.